Peachaphol Chongvoranond, “Sodium-Glucose Cotransporter-2 inhibitor (SGLT2i) Prescription Rates Amongst Diabetologists for Type 2 Diabetes Patients with Albuminuric Diabetic Kidney Disease:: A Real-World Study at a Diabetes Center in Bangkok”, J ASEAN Fed Endocr Soc, vol. 40, no. 2, pp. 69–77, Nov. 2025.